Previous 10 | Next 10 |
Bi-Flow is first bidirectional femoral arterial cannula validated for 29 days’ use LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, today announced its Bi-Flow Extracorporeal Membrane Oxygenation (ECMO) cannula earned CE Mark approval for E...
Various products can now be used to treat patients experiencing acute respiratory or cardiopulmonary failure LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, today announced that several of its cardiopulmonary products are now permitted to be used...
LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, will host a conference call to discuss its first quarter 2020 results on Wednesday, April 29, 2020 at 1 p.m. London time (8 a.m. Eastern Daylight Time). The Company will release its first quarter 2020 resu...
LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, today announced two abstracts focused on implantable neuromodulation technology for patients with heart failure will be shared at this year’s American College of Cardiology and World Congress of Ca...
This article is first in a series that provides an ongoing analysis of the changes made to Harris Associates' 13F stock portfolio on a quarterly basis. It is based on Harris Associates’ regulatory 13F Form filed on 02/14/2020. William Nygren’s 13F portfolio value increased ~10%...
Two UK patients receive innovative VNS Therapy implantable device through new pathway LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, today announced its Vagus Nerve Stimulation Therapy ® (VNS Therapy) System, Symmetry™, earned CE Ma...
Image source: The Motley Fool. LivaNova PLC (NASDAQ: LIVN) Q4 2019 Earnings Call Feb 26, 2020 , 8:00 a.m. ET Operator Continue reading
RECOVER sub-study will leverage Verily research tools to provide quantitative assessment measures of depressive episodes LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, today announced a research collaboration with Verily, an Alphabet company, to...
LivaNova PLC (LIVN) Q4 2019 Earnings Conference Call February 26, 2020 8:00 AM ET Company Participants Matthew Dodds - Senior Vice President of Corporate Development Damien McDonald - Chief Executive Officer Thad Huston - Chief Financial Officer Melissa Farina - Vice President ...
The following slide deck was published by LivaNova PLC in conjunction with their 2019 Q4 earnings Read more ...
News, Short Squeeze, Breakout and More Instantly...
2024-06-23 00:08:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, will host a conference call to discuss its second-quarter 2024 results on Wednesday, July 31, 2024 at 1 p.m. London time (8 a.m. Eastern Time). The Company will release its second-quarter 2024 results prior to the call. ...
2024-06-06 11:00:14 ET Rick Wise from Stifel Nicolaus issued a price target of $70.00 for LIVN on 2024-06-06 09:52:00. The adjusted price target was set to $70.00. At the time of the announcement, LIVN was trading at $53.16. The overall price target consensus is at $69.5...